...co-invested a $30 million fund for Masa Life Science Ventures. MSLV's portfolio includes dermatology company MediQuest Therapeutics Inc....

...Autoimmune, Infectious Date completed: 5/1/09 Type: Venture financing Raised: $23 million Investors: Not disclosed Note: MediQuest...

...MediQuest Therapeutics Inc. (Bothell, Wash.) said it raised $23 million in a series B round. MediQuest...

...page 5). SciBX 2(14); doi:10.1038/scibx.2009.575 Published online April 9, 2009 Polyamine transport inhibitors patented by MediQuest Therapeutics Inc....

...plus DFMO to treat SCCHN. Burns characterized the lysine-spermine conjugates while he was working at MediQuest Therapeutics Inc....
...Last year, he left the company and formed Aminex, which holds an exclusive license from MediQuest...
...Seattle, Wash. Cancer Prevention Pharmaceuticals LLC , Tucson, Ariz. Genzyme Corp. (NASDAQ:GENZ), Cambridge, Mass. MediQuest Therapeutics Inc....

...not disclose the contents of the letter. Vascana is a topical gel formulation of nitroglycerin. MediQuest Therapeutics Inc....

...4Q08 Medarex (NASDAQ:MEDX)/ Novartis (NYSE:NVS; SWX:NOVN) ACZ885 Cryopyrin-associated periodic syndromes (CAPS) Ph III data YE08 MediQuest...

...FDA accepted for filing and granted Priority Review to an NDA from MediQuest for MQX-503 to...
...disease. The PDUFA date is Oct. 28. MQX-503 is a topical gel formulation of nitroglycerin. MediQuest Therapeutics Inc....

...FDA accepted for filing and granted Priority Review to an NDA from MediQuest (Bothell, Wash.) for...